Global and Japan PCR-based Enteric Disease Testing Market Size, Status and Forecast 2021-2027

SKU ID :QYR-19209555 | Published Date: 23-Sep-2021 | No. of pages: 128
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Analyzers/Instruments 1.2.3 Kits/Panels 1.3 Market by Application 1.3.1 Global PCR-based Enteric Disease Testing Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Clostridium Difficile 1.3.3 Campylobacteriosis 1.3.4 Cholera 1.3.5 E. coli Infection 1.3.6 H. pylori Infection 1.3.7 Salmonellosis 1.3.8 Shigellosis 1.3.9 Rotavirus Infection 1.3.10 Norovirus Infection 1.3.11 Parasitic Enteric Disease 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global PCR-based Enteric Disease Testing Market Perspective (2016-2027) 2.2 PCR-based Enteric Disease Testing Growth Trends by Regions 2.2.1 PCR-based Enteric Disease Testing Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 PCR-based Enteric Disease Testing Historic Market Share by Regions (2016-2021) 2.2.3 PCR-based Enteric Disease Testing Forecasted Market Size by Regions (2022-2027) 2.3 PCR-based Enteric Disease Testing Industry Dynamic 2.3.1 PCR-based Enteric Disease Testing Market Trends 2.3.2 PCR-based Enteric Disease Testing Market Drivers 2.3.3 PCR-based Enteric Disease Testing Market Challenges 2.3.4 PCR-based Enteric Disease Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top PCR-based Enteric Disease Testing Players by Revenue 3.1.1 Global Top PCR-based Enteric Disease Testing Players by Revenue (2016-2021) 3.1.2 Global PCR-based Enteric Disease Testing Revenue Market Share by Players (2016-2021) 3.2 Global PCR-based Enteric Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by PCR-based Enteric Disease Testing Revenue 3.4 Global PCR-based Enteric Disease Testing Market Concentration Ratio 3.4.1 Global PCR-based Enteric Disease Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by PCR-based Enteric Disease Testing Revenue in 2020 3.5 PCR-based Enteric Disease Testing Key Players Head office and Area Served 3.6 Key Players PCR-based Enteric Disease Testing Product Solution and Service 3.7 Date of Enter into PCR-based Enteric Disease Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 PCR-based Enteric Disease Testing Breakdown Data by Type 4.1 Global PCR-based Enteric Disease Testing Historic Market Size by Type (2016-2021) 4.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2022-2027) 5 PCR-based Enteric Disease Testing Breakdown Data by Application 5.1 Global PCR-based Enteric Disease Testing Historic Market Size by Application (2016-2021) 5.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America PCR-based Enteric Disease Testing Market Size (2016-2027) 6.2 North America PCR-based Enteric Disease Testing Market Size by Type 6.2.1 North America PCR-based Enteric Disease Testing Market Size by Type (2016-2021) 6.2.2 North America PCR-based Enteric Disease Testing Market Size by Type (2022-2027) 6.2.3 North America PCR-based Enteric Disease Testing Market Size by Type (2016-2027) 6.3 North America PCR-based Enteric Disease Testing Market Size by Application 6.3.1 North America PCR-based Enteric Disease Testing Market Size by Application (2016-2021) 6.3.2 North America PCR-based Enteric Disease Testing Market Size by Application (2022-2027) 6.3.3 North America PCR-based Enteric Disease Testing Market Size by Application (2016-2027) 6.4 North America PCR-based Enteric Disease Testing Market Size by Country 6.4.1 North America PCR-based Enteric Disease Testing Market Size by Country (2016-2021) 6.4.2 North America PCR-based Enteric Disease Testing Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe PCR-based Enteric Disease Testing Market Size (2016-2027) 7.2 Europe PCR-based Enteric Disease Testing Market Size by Type 7.2.1 Europe PCR-based Enteric Disease Testing Market Size by Type (2016-2021) 7.2.2 Europe PCR-based Enteric Disease Testing Market Size by Type (2022-2027) 7.2.3 Europe PCR-based Enteric Disease Testing Market Size by Type (2016-2027) 7.3 Europe PCR-based Enteric Disease Testing Market Size by Application 7.3.1 Europe PCR-based Enteric Disease Testing Market Size by Application (2016-2021) 7.3.2 Europe PCR-based Enteric Disease Testing Market Size by Application (2022-2027) 7.3.3 Europe PCR-based Enteric Disease Testing Market Size by Application (2016-2027) 7.4 Europe PCR-based Enteric Disease Testing Market Size by Country 7.4.1 Europe PCR-based Enteric Disease Testing Market Size by Country (2016-2021) 7.4.2 Europe PCR-based Enteric Disease Testing Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size (2016-2027) 8.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type 8.2.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2016-2021) 8.2.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2022-2027) 8.2.3 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2016-2027) 8.3 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application 8.3.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2016-2021) 8.3.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2022-2027) 8.3.3 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2016-2027) 8.4 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region 8.4.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2016-2021) 8.4.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America PCR-based Enteric Disease Testing Market Size (2016-2027) 9.2 Latin America PCR-based Enteric Disease Testing Market Size by Type 9.2.1 Latin America PCR-based Enteric Disease Testing Market Size by Type (2016-2021) 9.2.2 Latin America PCR-based Enteric Disease Testing Market Size by Type (2022-2027) 9.2.3 Latin America PCR-based Enteric Disease Testing Market Size by Type (2016-2027) 9.3 Latin America PCR-based Enteric Disease Testing Market Size by Application 9.3.1 Latin America PCR-based Enteric Disease Testing Market Size by Application (2016-2021) 9.3.2 Latin America PCR-based Enteric Disease Testing Market Size by Application (2022-2027) 9.3.3 Latin America PCR-based Enteric Disease Testing Market Size by Application (2016-2027) 9.4 Latin America PCR-based Enteric Disease Testing Market Size by Country 9.4.1 Latin America PCR-based Enteric Disease Testing Market Size by Country (2016-2021) 9.4.2 Latin America PCR-based Enteric Disease Testing Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size (2016-2027) 10.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type 10.2.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2016-2021) 10.2.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2022-2027) 10.2.3 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2016-2027) 10.3 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application 10.3.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2016-2021) 10.3.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2022-2027) 10.3.3 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2016-2027) 10.4 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country 10.4.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2016-2021) 10.4.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Thermo Fisher Scientific 11.1.1 Thermo Fisher Scientific Company Details 11.1.2 Thermo Fisher Scientific Business Overview 11.1.3 Thermo Fisher Scientific PCR-based Enteric Disease Testing Introduction 11.1.4 Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.1.5 Thermo Fisher Scientific Recent Development 11.2 Vela Diagnostics 11.2.1 Vela Diagnostics Company Details 11.2.2 Vela Diagnostics Business Overview 11.2.3 Vela Diagnostics PCR-based Enteric Disease Testing Introduction 11.2.4 Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.2.5 Vela Diagnostics Recent Development 11.3 CorisBioconcept 11.3.1 CorisBioconcept Company Details 11.3.2 CorisBioconcept Business Overview 11.3.3 CorisBioconcept PCR-based Enteric Disease Testing Introduction 11.3.4 CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.3.5 CorisBioconcept Recent Development 11.4 Meridian Life Science 11.4.1 Meridian Life Science Company Details 11.4.2 Meridian Life Science Business Overview 11.4.3 Meridian Life Science PCR-based Enteric Disease Testing Introduction 11.4.4 Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.4.5 Meridian Life Science Recent Development 11.5 Bio-Rad Laboratories 11.5.1 Bio-Rad Laboratories Company Details 11.5.2 Bio-Rad Laboratories Business Overview 11.5.3 Bio-Rad Laboratories PCR-based Enteric Disease Testing Introduction 11.5.4 Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.5.5 Bio-Rad Laboratories Recent Development 11.6 Abbott (ALERE) 11.6.1 Abbott (ALERE) Company Details 11.6.2 Abbott (ALERE) Business Overview 11.6.3 Abbott (ALERE) PCR-based Enteric Disease Testing Introduction 11.6.4 Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.6.5 Abbott (ALERE) Recent Development 11.7 bioMerieux SA 11.7.1 bioMerieux SA Company Details 11.7.2 bioMerieux SA Business Overview 11.7.3 bioMerieux SA PCR-based Enteric Disease Testing Introduction 11.7.4 bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.7.5 bioMerieux SA Recent Development 11.8 Trinity Biotech 11.8.1 Trinity Biotech Company Details 11.8.2 Trinity Biotech Business Overview 11.8.3 Trinity Biotech PCR-based Enteric Disease Testing Introduction 11.8.4 Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.8.5 Trinity Biotech Recent Development 11.9 DiaSorin Molecular 11.9.1 DiaSorin Molecular Company Details 11.9.2 DiaSorin Molecular Business Overview 11.9.3 DiaSorin Molecular PCR-based Enteric Disease Testing Introduction 11.9.4 DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.9.5 DiaSorin Molecular Recent Development 11.10 Etta Healthcare (Ovagene Oncology) 11.10.1 Etta Healthcare (Ovagene Oncology) Company Details 11.10.2 Etta Healthcare (Ovagene Oncology) Business Overview 11.10.3 Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Introduction 11.10.4 Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.10.5 Etta Healthcare (Ovagene Oncology) Recent Development 11.11 ExcitePCR (PositiveID Corporation) 11.11.1 ExcitePCR (PositiveID Corporation) Company Details 11.11.2 ExcitePCR (PositiveID Corporation) Business Overview 11.11.3 ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Introduction 11.11.4 ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.11.5 ExcitePCR (PositiveID Corporation) Recent Development 11.12 Flow Alliance 11.12.1 Flow Alliance Company Details 11.12.2 Flow Alliance Business Overview 11.12.3 Flow Alliance PCR-based Enteric Disease Testing Introduction 11.12.4 Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.12.5 Flow Alliance Recent Development 11.13 Fluid-Screen 11.13.1 Fluid-Screen Company Details 11.13.2 Fluid-Screen Business Overview 11.13.3 Fluid-Screen PCR-based Enteric Disease Testing Introduction 11.13.4 Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.13.5 Fluid-Screen Recent Development 11.14 FluimediX 11.14.1 FluimediX Company Details 11.14.2 FluimediX Business Overview 11.14.3 FluimediX PCR-based Enteric Disease Testing Introduction 11.14.4 FluimediX Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.14.5 FluimediX Recent Development 11.15 Fluxergy 11.15.1 Fluxergy Company Details 11.15.2 Fluxergy Business Overview 11.15.3 Fluxergy PCR-based Enteric Disease Testing Introduction 11.15.4 Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.15.5 Fluxergy Recent Development 11.16 Focus Diagnostics (DiaSorin Molecular) 11.16.1 Focus Diagnostics (DiaSorin Molecular) Company Details 11.16.2 Focus Diagnostics (DiaSorin Molecular) Business Overview 11.16.3 Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Introduction 11.16.4 Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.16.5 Focus Diagnostics (DiaSorin Molecular) Recent Development 11.17 Future Horizon Scientific 11.17.1 Future Horizon Scientific Company Details 11.17.2 Future Horizon Scientific Business Overview 11.17.3 Future Horizon Scientific PCR-based Enteric Disease Testing Introduction 11.17.4 Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.17.5 Future Horizon Scientific Recent Development 11.18 Genalyte 11.18.1 Genalyte Company Details 11.18.2 Genalyte Business Overview 11.18.3 Genalyte PCR-based Enteric Disease Testing Introduction 11.18.4 Genalyte Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.18.5 Genalyte Recent Development 11.18 GeneFluidics 11.25.1 GeneFluidics Company Details 11.25.2 GeneFluidics Business Overview 11.25.3 GeneFluidics PCR-based Enteric Disease Testing Introduction 11.25.4 GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.25.5 GeneFluidics Recent Development 11.20 GenSpeed Biotech 11.20.1 GenSpeed Biotech Company Details 11.20.2 GenSpeed Biotech Business Overview 11.20.3 GenSpeed Biotech PCR-based Enteric Disease Testing Introduction 11.20.4 GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.20.5 GenSpeed Biotech Recent Development 11.21 Gulf Bio Analytical 11.21.1 Gulf Bio Analytical Company Details 11.21.2 Gulf Bio Analytical Business Overview 11.21.3 Gulf Bio Analytical PCR-based Enteric Disease Testing Introduction 11.21.4 Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.21.5 Gulf Bio Analytical Recent Development 11.22 Hahn-Schickard 11.22.1 Hahn-Schickard Company Details 11.22.2 Hahn-Schickard Business Overview 11.22.3 Hahn-Schickard PCR-based Enteric Disease Testing Introduction 11.22.4 Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.22.5 Hahn-Schickard Recent Development 11.23 Helvoet 11.23.1 Helvoet Company Details 11.23.2 Helvoet Business Overview 11.23.3 Helvoet PCR-based Enteric Disease Testing Introduction 11.23.4 Helvoet Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.23.5 Helvoet Recent Development 11.24 HemoCue 11.24.1 HemoCue Company Details 11.24.2 HemoCue Business Overview 11.24.3 HemoCue PCR-based Enteric Disease Testing Introduction 11.24.4 HemoCue Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.24.5 HemoCue Recent Development 11.25 Danaher 11.25.1 Danaher Company Details 11.25.2 Danaher Business Overview 11.25.3 Danaher PCR-based Enteric Disease Testing Introduction 11.25.4 Danaher Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.25.5 Danaher Recent Development 11.26 IDEX Health&Science 11.26.1 IDEX Health&Science Company Details 11.26.2 IDEX Health&Science Business Overview 11.26.3 IDEX Health&Science PCR-based Enteric Disease Testing Introduction 11.26.4 IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.26.5 IDEX Health&Science Recent Development 11.27 iLine Microsystems 11.27.1 iLine Microsystems Company Details 11.27.2 iLine Microsystems Business Overview 11.27.3 iLine Microsystems PCR-based Enteric Disease Testing Introduction 11.27.4 iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.27.5 iLine Microsystems Recent Development 11.28 Inflammatix 11.28.1 Inflammatix Company Details 11.28.2 Inflammatix Business Overview 11.28.3 Inflammatix PCR-based Enteric Disease Testing Introduction 11.28.4 Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2016-2021) 11.28.5 Inflammatix Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Analyzers/Instruments Table 3. Key Players of Kits/Panels Table 4. Global PCR-based Enteric Disease Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global PCR-based Enteric Disease Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global PCR-based Enteric Disease Testing Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global PCR-based Enteric Disease Testing Market Share by Regions (2016-2021) Table 8. Global PCR-based Enteric Disease Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global PCR-based Enteric Disease Testing Market Share by Regions (2022-2027) Table 10. PCR-based Enteric Disease Testing Market Trends Table 11. PCR-based Enteric Disease Testing Market Drivers Table 12. PCR-based Enteric Disease Testing Market Challenges Table 13. PCR-based Enteric Disease Testing Market Restraints Table 14. Global PCR-based Enteric Disease Testing Revenue by Players (2016-2021) & (US$ Million) Table 15. Global PCR-based Enteric Disease Testing Market Share by Players (2016-2021) Table 16. Global Top PCR-based Enteric Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PCR-based Enteric Disease Testing as of 2020) Table 17. Ranking of Global Top PCR-based Enteric Disease Testing Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by PCR-based Enteric Disease Testing Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players PCR-based Enteric Disease Testing Product Solution and Service Table 21. Date of Enter into PCR-based Enteric Disease Testing Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million) Table 24. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2016-2021) Table 25. Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global PCR-based Enteric Disease Testing Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global PCR-based Enteric Disease Testing Revenue Market Share by Application (2016-2021) Table 29. Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global PCR-based Enteric Disease Testing Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million) Table 32. North America PCR-based Enteric Disease Testing Market Size by Type (2022-2027) & (US$ Million) Table 33. North America PCR-based Enteric Disease Testing Market Size by Application (2016-2021) (US$ Million) Table 34. North America PCR-based Enteric Disease Testing Market Size by Application (2022-2027) & (US$ Million) Table 35. North America PCR-based Enteric Disease Testing Market Size by Country (2016-2021) & (US$ Million) Table 36. North America PCR-based Enteric Disease Testing Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million) Table 38. Europe PCR-based Enteric Disease Testing Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe PCR-based Enteric Disease Testing Market Size by Application (2016-2021) (US$ Million) Table 40. Europe PCR-based Enteric Disease Testing Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe PCR-based Enteric Disease Testing Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe PCR-based Enteric Disease Testing Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America PCR-based Enteric Disease Testing Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America PCR-based Enteric Disease Testing Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America PCR-based Enteric Disease Testing Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America PCR-based Enteric Disease Testing Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America PCR-based Enteric Disease Testing Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2022-2027) & (US$ Million) Table 61. Thermo Fisher Scientific Company Details Table 62. Thermo Fisher Scientific Business Overview Table 63. Thermo Fisher Scientific PCR-based Enteric Disease Testing Product Table 64. Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 65. Thermo Fisher Scientific Recent Development Table 66. Vela Diagnostics Company Details Table 67. Vela Diagnostics Business Overview Table 68. Vela Diagnostics PCR-based Enteric Disease Testing Product Table 69. Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 70. Vela Diagnostics Recent Development Table 71. CorisBioconcept Company Details Table 72. CorisBioconcept Business Overview Table 73. CorisBioconcept PCR-based Enteric Disease Testing Product Table 74. CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 75. CorisBioconcept Recent Development Table 76. Meridian Life Science Company Details Table 77. Meridian Life Science Business Overview Table 78. Meridian Life Science PCR-based Enteric Disease Testing Product Table 79. Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 80. Meridian Life Science Recent Development Table 81. Bio-Rad Laboratories Company Details Table 82. Bio-Rad Laboratories Business Overview Table 83. Bio-Rad Laboratories PCR-based Enteric Disease Testing Product Table 84. Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 85. Bio-Rad Laboratories Recent Development Table 86. Abbott (ALERE) Company Details Table 87. Abbott (ALERE) Business Overview Table 88. Abbott (ALERE) PCR-based Enteric Disease Testing Product Table 89. Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 90. Abbott (ALERE) Recent Development Table 91. bioMerieux SA Company Details Table 92. bioMerieux SA Business Overview Table 93. bioMerieux SA PCR-based Enteric Disease Testing Product Table 94. bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 95. bioMerieux SA Recent Development Table 96. Trinity Biotech Company Details Table 97. Trinity Biotech Business Overview Table 98. Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 99. Trinity Biotech Recent Development Table 100. DiaSorin Molecular Company Details Table 101. DiaSorin Molecular Business Overview Table 102. DiaSorin Molecular PCR-based Enteric Disease Testing Product Table 103. DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 104. DiaSorin Molecular Recent Development Table 105. Etta Healthcare (Ovagene Oncology) Company Details Table 106. Etta Healthcare (Ovagene Oncology) Business Overview Table 107. Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Product Table 108. Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 109. Etta Healthcare (Ovagene Oncology) Recent Development Table 110. ExcitePCR (PositiveID Corporation) Company Details Table 111. ExcitePCR (PositiveID Corporation) Business Overview Table 112. ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Product Table 113. ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 114. ExcitePCR (PositiveID Corporation) Recent Development Table 115. Flow Alliance Company Details Table 116. Flow Alliance Business Overview Table 117. Flow Alliance PCR-based Enteric Disease Testing Product Table 118. Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 119. Flow Alliance Recent Development Table 120. Fluid-Screen Company Details Table 121. Fluid-Screen Business Overview Table 122. Fluid-Screen PCR-based Enteric Disease Testing Product Table 123. Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 124. Fluid-Screen Recent Development Table 125. FluimediX Company Details Table 126. FluimediX Business Overview Table 127. FluimediX PCR-based Enteric Disease Testing Product Table 128. FluimediX Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 129. FluimediX Recent Development Table 130. Fluxergy Company Details Table 131. Fluxergy Business Overview Table 132. Fluxergy PCR-based Enteric Disease Testing Product Table 133. Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 134. Fluxergy Recent Development Table 135. Focus Diagnostics (DiaSorin Molecular) Company Details Table 136. Focus Diagnostics (DiaSorin Molecular) Business Overview Table 137. Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Product Table 138. Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 139. Focus Diagnostics (DiaSorin Molecular) Recent Development Table 140. Future Horizon Scientific Company Details Table 141. Future Horizon Scientific Business Overview Table 142. Future Horizon Scientific PCR-based Enteric Disease Testing Product Table 143. Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 144. Future Horizon Scientific Recent Development Table 145. Genalyte Company Details Table 146. Genalyte Business Overview Table 147. Genalyte PCR-based Enteric Disease Testing Product Table 148. Genalyte Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 149. Genalyte Recent Development Table 150. GeneFluidics Company Details Table 151. GeneFluidics Business Overview Table 152. GeneFluidics PCR-based Enteric Disease Testing Product Table 153. GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 154. GeneFluidics Recent Development Table 155. GenSpeed Biotech Company Details Table 156. GenSpeed Biotech Business Overview Table 157. GenSpeed Biotech PCR-based Enteric Disease Testing Product Table 158. GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 159. GenSpeed Biotech Recent Development Table 160. Gulf Bio Analytical Company Details Table 161. Gulf Bio Analytical Business Overview Table 162. Gulf Bio Analytical PCR-based Enteric Disease Testing Product Table 163. Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 164. Gulf Bio Analytical Recent Development Table 165. Hahn-Schickard Company Details Table 166. Hahn-Schickard Business Overview Table 167. Hahn-Schickard PCR-based Enteric Disease Testing Product Table 168. Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 169. Hahn-Schickard Recent Development Table 170. Helvoet Company Details Table 171. Helvoet Business Overview Table 172. Helvoet PCR-based Enteric Disease Testing Product Table 173. Helvoet Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 174. Helvoet Recent Development Table 175. HemoCue Company Details Table 176. HemoCue Business Overview Table 177. HemoCue PCR-based Enteric Disease TestingProduct Table 178. HemoCue Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 179. HemoCue Recent Development Table 180. Danaher Company Details Table 181. Danaher Business Overview Table 182. Danaher PCR-based Enteric Disease Testing Product Table 183. Danaher Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 184. Danaher Recent Development Table 185. IDEX Health&Science Company Details Table 186. IDEX Health&Science Business Overview Table 187. IDEX Health&Science PCR-based Enteric Disease Testing Product Table 188. IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 189. IDEX Health&Science Recent Development Table 190. iLine Microsystems Company Details Table 191. iLine Microsystems Business Overview Table 192. iLine Microsystems PCR-based Enteric Disease Testing Product Table 193. iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 194. iLine Microsystems Recent Development Table 195. Inflammatix Company Details Table 196. Inflammatix Business Overview Table 197. Inflammatix PCR-based Enteric Disease Testing Product Table 198. Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million) Table 199. Inflammatix Recent Development Table 200. Research Programs/Design for This Report Table 201. Key Data Information from Secondary Sources Table 202. Key Data Information from Primary Sources List of Figures Figure 1. Global PCR-based Enteric Disease Testing Market Share by Type: 2020 VS 2027 Figure 2. Analyzers/Instruments Features Figure 3. Kits/Panels Features Figure 4. Global PCR-based Enteric Disease Testing Market Share by Application: 2020 VS 2027 Figure 5. Clostridium Difficile Case Studies Figure 6. Campylobacteriosis Case Studies Figure 7. Cholera Case Studies Figure 8. E. coli Infection Case Studies Figure 9. H. pylori Infection Case Studies Figure 10. Salmonellosis Case Studies Figure 11. Shigellosis Case Studies Figure 12. Rotavirus Infection Case Studies Figure 13. Norovirus Infection Case Studies Figure 14. Parasitic Enteric Disease Case Studies Figure 15. PCR-based Enteric Disease Testing Report Years Considered Figure 16. Global PCR-based Enteric Disease Testing Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 17. Global PCR-based Enteric Disease Testing Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 18. Global PCR-based Enteric Disease Testing Market Share by Regions: 2020 VS 2027 Figure 19. Global PCR-based Enteric Disease Testing Market Share by Regions (2022-2027) Figure 20. Global PCR-based Enteric Disease Testing Market Share by Players in 2020 Figure 21. Global Top PCR-based Enteric Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PCR-based Enteric Disease Testing as of 2020 Figure 22. The Top 10 and 5 Players Market Share by PCR-based Enteric Disease Testing Revenue in 2020 Figure 23. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2016-2021) Figure 24. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2022-2027) Figure 25. North America PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. North America PCR-based Enteric Disease Testing Market Share by Type (2016-2027) Figure 27. North America PCR-based Enteric Disease Testing Market Share by Application (2016-2027) Figure 28. North America PCR-based Enteric Disease Testing Market Share by Country (2016-2027) Figure 29. United States PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Canada PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Europe PCR-based Enteric Disease Testing Market Share by Type (2016-2027) Figure 33. Europe PCR-based Enteric Disease Testing Market Share by Application (2016-2027) Figure 34. Europe PCR-based Enteric Disease Testing Market Share by Country (2016-2027) Figure 35. Germany PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. France PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. U.K. PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Italy PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Russia PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Nordic PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Asia-Pacific PCR-based Enteric Disease Testing Market Share by Type (2016-2027) Figure 43. Asia-Pacific PCR-based Enteric Disease Testing Market Share by Application (2016-2027) Figure 44. Asia-Pacific PCR-based Enteric Disease Testing Market Share by Region (2016-2027) Figure 45. China PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Japan PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. South Korea PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Southeast Asia PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. India PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Australia PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Latin America PCR-based Enteric Disease Testing Market Share by Type (2016-2027) Figure 53. Latin America PCR-based Enteric Disease Testing Market Share by Application (2016-2027) Figure 54. Latin America PCR-based Enteric Disease Testing Market Share by Country (2016-2027) Figure 55. Mexico PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Brazil PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Middle East & Africa PCR-based Enteric Disease Testing Market Share by Type (2016-2027) Figure 59. Middle East & Africa PCR-based Enteric Disease Testing Market Share by Application (2016-2027) Figure 60. Middle East & Africa PCR-based Enteric Disease Testing Market Share by Country (2016-2027) Figure 61. Turkey PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Saudi Arabia PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. UAE PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. Thermo Fisher Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 65. Vela Diagnostics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 66. CorisBioconcept Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 67. Meridian Life Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 68. Bio-Rad Laboratories Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 69. Abbott (ALERE) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 70. bioMerieux SA Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 71. Trinity Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 72. DiaSorin Molecular Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 73. Etta Healthcare (Ovagene Oncology) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 74. ExcitePCR (PositiveID Corporation) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 75. Flow Alliance Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 76. Fluid-Screen Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 77. FluimediX Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 78. Fluxergy Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 79. Focus Diagnostics (DiaSorin Molecular) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 80. Future Horizon Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 81. Genalyte Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 82. GeneFluidics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 83. GenSpeed Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 84. Gulf Bio Analytical Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 85. Hahn-Schickard Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 86. Helvoet Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 87. HemoCue Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 88. Danaher Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 89. IDEX Health&Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 90. iLine Microsystems Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 91. Inflammatix Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021) Figure 92. Bottom-up and Top-down Approaches for This Report Figure 93. Data Triangulation Figure 94. Key Executives Interviewed
Thermo Fisher Scientific Vela Diagnostics CorisBioconcept Meridian Life Science Bio-Rad Laboratories Abbott (ALERE) bioMerieux SA Trinity Biotech DiaSorin Molecular Etta Healthcare (Ovagene Oncology) ExcitePCR (PositiveID Corporation) Flow Alliance Fluid-Screen FluimediX Fluxergy Focus Diagnostics (DiaSorin Molecular) Future Horizon Scientific Genalyte GeneFluidics GenSpeed Biotech Gulf Bio Analytical Hahn-Schickard Helvoet HemoCue Danaher IDEX Health&Science iLine Microsystems Inflammatix
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients